These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25002580)
21. In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin). Støy J; Olsen J; Park SY; Gregersen S; Hjørringgaard CU; Bell GI Diabetologia; 2017 Aug; 60(8):1423-1431. PubMed ID: 28478482 [TBL] [Abstract][Full Text] [Related]
22. Disulfide Mispairing During Proinsulin Folding in the Endoplasmic Reticulum. Haataja L; Manickam N; Soliman A; Tsai B; Liu M; Arvan P Diabetes; 2016 Apr; 65(4):1050-60. PubMed ID: 26822090 [TBL] [Abstract][Full Text] [Related]
23. "Register-shift" insulin analogs uncover constraints of proteotoxicity in protein evolution. Rege NK; Liu M; Dhayalan B; Chen YS; Smith NA; Rahimi L; Sun J; Guo H; Yang Y; Haataja L; Phillips NFB; Whittaker J; Smith BJ; Arvan P; Ismail-Beigi F; Weiss MA J Biol Chem; 2020 Mar; 295(10):3080-3098. PubMed ID: 32005662 [TBL] [Abstract][Full Text] [Related]
24. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. Liu M; Haataja L; Wright J; Wickramasinghe NP; Hua QX; Phillips NF; Barbetti F; Weiss MA; Arvan P PLoS One; 2010 Oct; 5(10):e13333. PubMed ID: 20948967 [TBL] [Abstract][Full Text] [Related]
25. Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes. Liu M; Lara-Lemus R; Shan SO; Wright J; Haataja L; Barbetti F; Guo H; Larkin D; Arvan P Diabetes; 2012 Apr; 61(4):828-37. PubMed ID: 22357960 [TBL] [Abstract][Full Text] [Related]
26. Misfolded proinsulin affects bystander proinsulin in neonatal diabetes. Hodish I; Liu M; Rajpal G; Larkin D; Holz RW; Adams A; Liu L; Arvan P J Biol Chem; 2010 Jan; 285(1):685-94. PubMed ID: 19880509 [TBL] [Abstract][Full Text] [Related]
27. Biophysical alteration of the secretory track in β-cells due to molecular overcrowding: the relevance for diabetes. Ionescu-Tirgoviste C; Despa F Integr Biol (Camb); 2011 Mar; 3(3):173-9. PubMed ID: 21180710 [TBL] [Abstract][Full Text] [Related]
28. INS-gene mutations: from genetics and beta cell biology to clinical disease. Liu M; Sun J; Cui J; Chen W; Guo H; Barbetti F; Arvan P Mol Aspects Med; 2015 Apr; 42():3-18. PubMed ID: 25542748 [TBL] [Abstract][Full Text] [Related]
29. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. Balboa D; Saarimäki-Vire J; Borshagovski D; Survila M; Lindholm P; Galli E; Eurola S; Ustinov J; Grym H; Huopio H; Partanen J; Wartiovaara K; Otonkoski T Elife; 2018 Nov; 7():. PubMed ID: 30412052 [TBL] [Abstract][Full Text] [Related]
30. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. Colombo C; Porzio O; Liu M; Massa O; Vasta M; Salardi S; Beccaria L; Monciotti C; Toni S; Pedersen O; Hansen T; Federici L; Pesavento R; Cadario F; Federici G; Ghirri P; Arvan P; Iafusco D; Barbetti F; J Clin Invest; 2008 Jun; 118(6):2148-56. PubMed ID: 18451997 [TBL] [Abstract][Full Text] [Related]
31. In vitro folding of methionine-arginine human lyspro-proinsulin S-sulfonate-disulfide formation pathways and factors controlling yield. Chen S; Adijanto L; Wang NH Biotechnol Prog; 2010; 26(5):1332-43. PubMed ID: 20540164 [TBL] [Abstract][Full Text] [Related]
32. Alanine scanning mutants of rat proinsulin I show functional diversity of anti-insulin monoclonal antibodies. Tikhomirov OY; Thomas JW J Immunol; 2000 Oct; 165(7):3876-82. PubMed ID: 11034394 [TBL] [Abstract][Full Text] [Related]
33. Diabetes mellitus due to toxic misfolding of proinsulin variants. Dhayalan B; Chatterjee D; Chen YS; Weiss MA Mol Metab; 2021 Apr; ():101229. PubMed ID: 33823319 [TBL] [Abstract][Full Text] [Related]
34. Novel Pathogenic De Novo INS p.T97P Variant Presenting With Severe Neonatal DKA. Lal RA; Moeller HP; Thomson EA; Horton TM; Lee S; Freeman R; Prahalad P; Poon ASY; Annes JP Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34888628 [TBL] [Abstract][Full Text] [Related]
35. Total chemical synthesis of human proinsulin. Luisier S; Avital-Shmilovici M; Weiss MA; Kent SB Chem Commun (Camb); 2010 Nov; 46(43):8177-9. PubMed ID: 20877850 [TBL] [Abstract][Full Text] [Related]
36. Effects of proinsulin misfolding on β-cell dynamics, differentiation and function in diabetes. Riahi Y; Israeli T; Cerasi E; Leibowitz G Diabetes Obes Metab; 2018 Sep; 20 Suppl 2():95-103. PubMed ID: 30230182 [TBL] [Abstract][Full Text] [Related]
37. Genetic complexity in a Drosophila model of diabetes-associated misfolded human proinsulin. Park SY; Ludwig MZ; Tamarina NA; He BZ; Carl SH; Dickerson DA; Barse L; Arun B; Williams CL; Miles CM; Philipson LH; Steiner DF; Bell GI; Kreitman M Genetics; 2014 Feb; 196(2):539-55. PubMed ID: 24281154 [TBL] [Abstract][Full Text] [Related]
39. A Novel c.125 T>G (p.Val42Gly) Mutation in The Human INS Gene Leads to Neonatal Diabetes Mellitus via a Decrease in Insulin Synthesis. Sun F; Du W; Ma J; Gu M; Wang J; Zhu H; Song H; Gao G Exp Clin Endocrinol Diabetes; 2020 Mar; 128(3):182-189. PubMed ID: 29890547 [TBL] [Abstract][Full Text] [Related]
40. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area. Breuer TG; Menge BA; Banasch M; Uhl W; Tannapfel A; Schmidt WE; Nauck MA; Meier JJ Eur J Endocrinol; 2010 Oct; 163(4):551-8. PubMed ID: 20679359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]